Bicalutamide is a second generation, oral nonsteroidal antiandrogen similar in structure to flutamide that has been used widely in the therapy of prostate cancer. Bicalutamide is associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of liver injury. It is grouped under the following drug class(es): Androgen receptor inhibitors and Sulfones. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Casodex, Kalumid and Calutide. Its PubChem CID is 2375.
Bicalutamide
| CAS No | 90357-06-5 |
|---|---|
| Molecular Formula | C18H14F4N2O4S |
| Molecular Weight | 430.4 g/mol |
| Synonyms | N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bicalutamide is a second generation, oral nonsteroidal antiandrogen similar in structure to flutamide that has been used widely in the therapy of prostate cancer.
The listed CAS number is 90357-06-5.
The listed molecular formula is C18H14F4N2O4S.
The listed molecular weight is 430.4 g/mol.
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide.
The source lists Casodex, Kalumid and Calutide.